Progress of research on clinical treatment of renal tuberculosis
10.11816/cn.ni.2025-246940
- VernacularTitle:肾结核临床治疗研究进展
- Author:
Xiaoshan LI
1
;
Yuyang ZHANG
;
Xiumei LI
;
Tiantian HOU
;
Panfeng SHANG
Author Information
1. 兰州大学第二医院泌尿外科,甘肃 兰州 730030
- Publication Type:Journal Article
- Keywords:
Urogenital tuberculosis;
Renal tuberculosis;
Anti-tuberculosis drugs;
Drug-resistant tuberculosis;
Complications;
Drug therapy;
Surgical treatment
- From:
Chinese Journal of Nosocomiology
2025;35(15):2395-2400
- CountryChina
- Language:Chinese
-
Abstract:
Drug therapy and surgical treatment are the two primary methods for treating renal tuberculosis.With the increase in drug-resistant strains,some novel anti-tuberculosis drugs,such as Delamanid and Bedaquiline,are being developed and gradually applied in clinical practice.Surgical treatment is suitable for patients with poor re-sponses to drug therapy and those who develop complications.Surgical methods include nephrectomy and partial nephrectomy.As the goal of preserving renal function as much as possible becomes more important,minimally in-vasive treatments have been adopted,with significant contributions from percutaneous nephrostomy and ureteral stent placement.Additionally,immunotherapy has emerged as a new direction,with immunomodulators such as interferons and interleukins under investigation.This article discusses the status and research progress in the treat-ment of renal tuberculosis,aiming to provide a theoretical basis for future treatments.
